Illumina, Bill Gates & Jeff Bezos launched startup GRAIL to develop blood-based cancer tests

Jan 12, 2016 15:56 IST

Illumina, the world’s largest DNA sequencing company, on 10 January 2016 announced the launch of the startup named GRAIL to develop blood-based cancer tests.

The company was launched in association with Microsoft co-founder Bill Gates, Amazon CEO Jeff Bezo’s venture fund Bezos Expeditions and Arch Venture Partners.

Details related to Illumina

• The company will develop blood tests that cost 1000 US dollars or less for detecting many types of cancer before symptoms arise.
• The test, which is also called as liquid biopsy, will use high-speed DNA sequencing machines to scour a person’s blood for fragments of DNA released by cancer cells.
• All the partners in the startup raised around 100 million US dollars among themselves, in which Illumina will have the majority stake holder.
• The newly developed tests are expected to reach the market by 2019.
• GRAIL will operate from San Diego in California, the USA.

Now get latest Current Affairs on mobile, Download # 1  Current Affairs App

 

Is this article important for exams ? Yes2 People Agreed
Read more Current Affairs on: blood tests for cancer , Grail , DNA sequencing , Illumina , Bill Gates , Jeff Bezos , Amazon

DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.

Latest Videos

Register to get FREE updates

    All Fields Mandatory
  • (Ex:9123456789)
  • Please Select Your Interest
  • Please specify

  • ajax-loader
  • A verifcation code has been sent to
    your mobile number

    Please enter the verification code below

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK